STOCK TITAN

LifeMD to Participate in Upcoming Investor Conferences and Webinar

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
LifeMD, Inc. (LFMD) announced participation in multiple investor conferences and a webinar to discuss GLP-1s. CEO Justin Schreiber will be presenting at various events to engage with investors and analysts.
Positive
  • None.
Negative
  • None.

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced that management will be participating in three upcoming investor conferences and a webinar discussing GLP-1s.

  • D.A. Davidson GLP-1 Webinar, February 26, 2024. Justin Schreiber, Chief Executive Officer of LifeMD, will participate in a webinar with equity research analysts Gil Luria and Linda Bolton Weiser to discuss his perspective on GLP-1s.

  • TD Cowen’s 44th Annual Health Care Conference, March 4-6, 2024 at the Boston Marriott Copley Place. Management will be presenting a corporate overview and will be holding one-on-one meetings with investors.

  • Oppenheimer 34th Annual Healthcare MedTech & Services Conference, March 12-13, 2024. Management will deliver a virtual company presentation and will hold one-on-one virtual meetings with investors.

  • KeyBanc Capital Markets Life Sciences & MedTech Investor Forum: Virtual, March 19-20, 2024. Management will be participating in a virtual fireside chat and will be holding one-on-one virtual meetings with investors.

About LifeMD, Inc.
LifeMD is a leading provider of virtual primary care. LifeMD offers telemedicine, laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s health, women’s health, allergy & asthma, and dermatology. The Company leverages a vertically-integrated, proprietary digital care platform, a 50-state affiliated medical group, and a U.S.-based patient care center to increase access to top-notch and affordable care. For more information, please visit LifeMD.com.

Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com

Media Contact
Jessica Friedeman, Chief Marketing Officer
press@lifemd.com


The D.A. Davidson GLP-1 Webinar is scheduled for February 26, 2024.

The TD Cowen’s 44th Annual Health Care Conference will take place at the Boston Marriott Copley Place from March 4-6, 2024.

The focus of the Oppenheimer 34th Annual Healthcare MedTech & Services Conference is on delivering a virtual company presentation and engaging in one-on-one virtual meetings with investors.

The KeyBanc Capital Markets Life Sciences & MedTech Investor Forum is a virtual event where management will participate in a fireside chat and hold one-on-one virtual meetings with investors.
LifeMD Inc

NASDAQ:LFMD

LFMD Rankings

LFMD Latest News

LFMD Stock Data

Medicinal and Botanical Manufacturing
Manufacturing
Link

About LFMD

lifemd is a comprehensive one-stop telemedicine/telehealth solution with a platform that provides a fully integrated telehealth solution to connect physicians, medical providers, pharmacists, and patients worldwide. the platform is hipaa-compliant and all interactions and communication between physicians, healthcare providers and patients are aes-encrypted. the platform allows physicians, healthcare providers and patients to securely connect and manage common medical conditions. lifemd also custom fabricates mobile diagnostic telehealth equipment such as cases, carts and kiosks. the service is available 24/7/365.